Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2026-04-24 Earnings Release
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR DOUBLE-CRANE FOR THE THREE MONTHS ENDED 31 MARCH 2026
Earnings Release Classification · 85% confidence The document is an announcement summarizing key unaudited financial results for the three months ended 31 March 2026 (revenue, net profit, cash balances, assets/liabilities). It clearly provides highlights rather than the full report and points investors to the full quarterly report on the exchange website. This matches the definition of an Earnings Release (ER) as an initial announcement of quarterly/periodical financial results with key highlights only. Q1 2026
2026-04-24 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF DONG-E-E-JIAO FOR THE THREE MONTHS ENDED 31 MARCH 2026
Earnings Release Classification · 88% confidence The document is an announcement by China Resources Pharmaceutical Group Limited summarizing the key unaudited financial metrics for the three months ended 31 March 2026 (revenue, net profit, assets, etc.) rather than the full quarterly report itself. It explicitly states this is an announcement of quarterly financial results (key highlights only) and refers readers to the subsidiary’s website for the full report. This matches the “Earnings Release” definition (initial announcement of quarterly/periodical financial results). Q1 2026
2026-04-24 English
INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE FIRST TRANCHE OF 2026 CORPORATE BONDS IN THE PRC
Capital/Financing Update Classification · 90% confidence The document is an inside information announcement on the Hong Kong Stock Exchange regarding the completion of a public issuance of corporate bonds (the first tranche of 2026 corporate bonds) by a wholly-owned subsidiary, detailing the principal amount, coupon rate, and intended use of proceeds. This is a financing activity announcement rather than a full report, board change, dividend, or regulatory filing notice. It falls squarely under Capital/Financing Update.
2026-04-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
Regulatory Filings Classification · 85% confidence The document is a standard monthly return (Form FF301) filed with the Hong Kong Stock Exchange under Chapter 19B of the Listing Rules, detailing movements in issued and treasury shares and public float sufficiency. It is a mandated regulatory submission rather than a standalone financial report, new share issue announcement, or dividend notice. It does not present full financial statements, management commentary, or call transcripts, nor is it a notice of report publication; rather it is a recurring regulatory compliance filing. The appropriate category is Regulatory Filings (RNS).
2026-04-01 English
INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE FIRST TRANCHE OF 2026 CORPORATE BONDS IN THE PRC
Capital/Financing Update Classification · 91% confidence The document is an announcement under Hong Kong Listing Rules regarding the completion of a corporate bond issuance (the first tranche of 2026 bonds) by a subsidiary, detailing the principal amount, term, coupon rate, and intended use of proceeds. It is clearly a financing activity update rather than a full report, earnings release, or regulatory filing of another type. Therefore, it falls under Capital/Financing Update (Code: CAP).
2026-03-27 English
INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE FIRST TRANCHE OF 2026 CORPORATE BONDS IN THE PRC
Capital/Financing Update Classification · 92% confidence The document is an official stock exchange announcement under Hong Kong Listing Rules regarding the completion of a corporate bond issuance by a subsidiary, detailing the tranche size, use of proceeds, and coupon rate. It is not an earnings release, annual report, management change, or proxy material, but an update on company financing activities (bond issuance). This corresponds to the “Capital/Financing Update” category (Code: CAP).
2026-03-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.